Insmed, Inc. (INSM)
117.84
+1.84
(+1.59%)
USD |
NASDAQ |
May 13, 16:00
117.84
0.00 (0.00%)
After-Hours: 17:18
Insmed Cash from Investing (Quarterly) : 265.52M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 192.19M |
| ACADIA Pharmaceuticals, Inc. | 66.28M |
| PTC Therapeutics, Inc. | -93.74M |
| United Therapeutics Corp. | 743.70M |
| Protagonist Therapeutics, Inc. | 90.89M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -222.74M |
| Cash from Financing (Quarterly) | 29.51M |
| Free Cash Flow | -951.64M |
| Free Cash Flow Per Share (Quarterly) | -1.050 |
| Free Cash Flow to Equity (Quarterly) | -218.67M |
| Free Cash Flow to Firm (Quarterly) | -205.95M |
| Free Cash Flow Yield | -3.89% |